PLX - Protalix BioTherapeutics, Inc.

NYSE American - Nasdaq Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Jun 2018)Next Qtr. (Sep 2018)Current Year (2018)Next Year (2019)
No. of Analysts2222
Avg. Estimate-0.06-0.04-0.2-0.07
Low Estimate-0.07-0.06-0.26-0.21
High Estimate-0.04-0.02-0.130.07
Year Ago EPS-0.06-0.09-0.61-0.2
Revenue EstimateCurrent Qtr. (Jun 2018)Next Qtr. (Sep 2018)Current Year (2018)Next Year (2019)
No. of Analysts2222
Avg. Estimate7M8.9M30.15M46.1M
Low Estimate6M7.8M25.9M32.2M
High Estimate8M10M34.4M60M
Year Ago Sales6.36M7.53M19.24M30.15M
Sales Growth (year/est)10.10%18.30%56.70%52.90%
Earnings History6/29/20179/29/201712/30/20173/30/2018
EPS Est.-0.04-0.05-0.06-0.09
EPS Actual-0.06-0.09-0.06-0.06
Difference-0.02-0.0400.03
Surprise %-50.00%-80.00%0.00%33.30%
EPS TrendCurrent Qtr. (Jun 2018)Next Qtr. (Sep 2018)Current Year (2018)Next Year (2019)
Current Estimate-0.06-0.04-0.2-0.07
7 Days Ago-0.06-0.04-0.2-0.07
30 Days Ago-0.06-0.04-0.2-0.07
60 Days Ago-0.06-0.04-0.20.19
90 Days Ago-0.06-0.04-0.210.19
EPS RevisionsCurrent Qtr. (Jun 2018)Next Qtr. (Sep 2018)Current Year (2018)Next Year (2019)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesPLXIndustrySectorS&P 500
Current Qtr.N/AN/AN/A0.43
Next Qtr.55.60%N/AN/A0.47
Current Year67.20%N/AN/A0.22
Next Year65.00%N/AN/A0.10
Next 5 Years (per annum)25.00%N/AN/A0.11
Past 5 Years (per annum)N/AN/AN/AN/A